Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Genetic studies in Japanese multiplex families identified homozygous (M78V-V343A/M78V-V343A) and compound heterozygous (R337X/V343A) COQ2 mutations segregating with MSA in two pedigrees (PMID:23758206). Subsequent East Asian case–control series and a meta-analysis encompassing Japanese, Korean, mainland Chinese, and Taiwanese cohorts demonstrated a significant association of the heterozygous c.1178T>C (p.Val393Ala) susceptibility variant with the cerebellar subtype of MSA (MSA-C; pooled OR 2.12, p = 0.004) (PMID:26590992; PMID:34455210). However, large cohorts from Italy and the United States failed to replicate these findings in Caucasian populations (PMID:31398377; PMID:25373618), and a cosegregation analysis of the c.-23C>G variant did not support pathogenicity (PMID:27394078). Overall, an autosomal recessive inheritance model with incomplete penetrance is proposed but remains unconfirmed.
Functional assays confirm that COQ2 missense and loss-of-function variants impair para-hydroxybenzoate-polyprenyltransferase activity, leading to deficient coenzyme Q10 biosynthesis in patient fibroblasts and yeast complementation models (PMID:16400613; PMID:17374725). CoQ10 levels are significantly reduced in the cerebellum of MSA patients and in plasma of MSA cohorts, supporting a pathogenic mechanism driven by mitochondrial dysfunction and oxidative stress independent of COQ2 genotype (PMID:27235405; PMID:27356913). Despite strong mechanistic plausibility, inconsistent replication across populations and limited segregation data yield a Limited classification. COQ2 genotyping in MSA-C patients may inform risk stratification and highlight potential benefit from CoQ10 supplementation.
Gene–Disease AssociationLimitedRecessive COQ2 mutations segregating in two Japanese families and heterozygous susceptibility variant in East Asian cohorts, but lacking consistent replication and insufficient segregation. Genetic EvidenceLimitedRecessive mutations in 2 families and association studies in ~500 East Asian cases, but negative replication in Caucasian cohorts. Functional EvidenceModerateCellular and yeast assays demonstrate impaired COQ2 activity and CoQ10 biosynthesis; reduced CoQ10 levels observed in MSA patient tissues. |